Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Total 13F shares
-
53,330,829
-
Share change
-
+5,956,997
-
Total reported value
-
$387,201,104
-
Put/Call ratio
-
33%
-
Price per share
-
$7.26
-
Number of holders
-
135
-
Value change
-
+$44,065,843
-
Number of buys
-
84
-
Number of sells
-
43
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q4 2016
As of 31 Dec 2016,
CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,330,829 shares.
The largest 10 holders included
FEDERATED INVESTORS INC /PA/, INGALLS & SNYDER LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, INVESTOR AB, Invesco Ltd., and STATE STREET CORP.
This page lists
135
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.